The company attributes its success to a collaboration with the Vatican Pontifical Council for Culture to expand and raise awareness of the adult stem cell research, a $700,000 contract with the U.S. Army Medical Research and Materiel Command regarding the VSEL technology and research sponsored with Harvard Medical School affiliate Schepens Eye Research Institute.
The company reported cash and cash equivalents of approximately $11 million at the end of the second quarter.
Read the release on NeoStem’s 2Q FY 2010 report.
Read other coverage on orthopedic device company reports:
– Smith & Nephew Reports 4% Increase in 2Q Revenue
– Medtronic Posts FY 2010 of $15.8B
– Biomet Announces 4Q FY 2010 Financial Results
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.